Cargando…
Optical Coherence Tomography as a Biomarker for Diagnosis, Progression, and Prognosis of Neurodegenerative Diseases
Neurodegenerative diseases present a current challenge for accurate diagnosis and for providing precise prognostic information. Developing imaging biomarkers for multiple sclerosis (MS), Parkinson disease (PD), and Alzheimer's disease (AD) will improve the clinical management of these patients...
Autores principales: | Satue, Maria, Obis, Javier, Rodrigo, Maria J., Otin, Sofia, Fuertes, Maria I., Vilades, Elisa, Gracia, Hector, Ara, Jose R., Alarcia, Raquel, Polo, Vicente, Larrosa, Jose M., Pablo, Luis E., Garcia-Martin, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093273/ https://www.ncbi.nlm.nih.gov/pubmed/27840739 http://dx.doi.org/10.1155/2016/8503859 |
Ejemplares similares
-
Ability of Swept-Source Optical Coherence Tomography to Detect Retinal and Choroidal Changes in Patients with Multiple Sclerosis
por: Garcia-Martin, Elena, et al.
Publicado: (2018) -
Angiography with optical coherence tomography as a biomarker in multiple sclerosis
por: Cordon, Beatriz, et al.
Publicado: (2020) -
Comparison of peripapillary choroidal thickness between healthy subjects and patients with Parkinson’s disease
por: Garcia-Martin, Elena, et al.
Publicado: (2017) -
Physiological changes in retinal layers thicknesses measured with swept source optical coherence tomography
por: Viladés, Elisa, et al.
Publicado: (2020) -
Relationship between Visual Dysfunction and Retinal Changes in Patients with Multiple Sclerosis
por: Satue, Maria, et al.
Publicado: (2016)